News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Slideshows|August 21, 2019

How to help parents after SUDC

Author(s)Erin Bowen, MD, FAAP

Here are 12 important steps that pediatricians can take to support families after the sudden death of a child.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Megan Cole Brahim, PhD, on addressing mental health concerns during pediatric primary care visits

Megan Cole Brahim, PhD, on addressing mental health concerns during pediatric primary care visits

ByMegan Cole Brahim, PhD, MPH

June 11th 2026

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

ByKevin Kunzmann,Morgan Ebert, Executive Editor

June 11th 2026

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

ByMorgan Ebert, Executive Editor

June 10th 2026

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

ByMorgan Ebert, Executive Editor

June 10th 2026

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

ByMorgan Ebert, Executive Editor

June 10th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

New sunscreen ingredient clears FDA for the first time since the 1990s

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

Earlier egg introduction guidelines linked to measurable decline in infant egg allergy prevalence

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease